What is an ibogaine ceremony?

An ibogaine ceremony involves a single oral dose of ibogaine — an alkaloid from the root bark of Tabernanthe iboga — administered under medical supervision. The active pharmacological experience lasts 12–24 hours, during which a physician must be physically present and cardiac monitoring must run continuously. Recovery takes 2–3 additional days. The integration period that follows — typically 8–12 weeks — is what determines whether any lasting change results.

How long does an ibogaine ceremony last?

The active pharmacological experience lasts 12–24 hours. Recovery — during which the person rests and is monitored — takes an additional 2–3 days. Most participants spend 4–5 days at the facility in total. The integration period that follows is the most consequential phase and typically runs 8–12 weeks, during which noribogaine remains biologically active and neuroplasticity is elevated.

What is the difference between an ibogaine ceremony and an iboga ceremony?

An iboga ceremony uses the whole root bark of Tabernanthe iboga in its traditional Bwiti form — typically involving music, chanting, and a ceremonial structure specific to the Gabonese and Cameroonian traditions in which iboga has been used for centuries. An ibogaine ceremony uses the isolated alkaloid — ibogaine HCl or total alkaloid extract — in a more clinical or hybrid facilitation context. The pharmacological core is similar; the ritual framework differs substantially.

Is ibogaine ceremony legal in Canada?

Ibogaine is not listed under Canada's Controlled Drugs and Substances Act and is not approved for medical use. It is not explicitly prohibited — a meaningfully different legal status from the United States, where ibogaine has been Schedule I since 1970, or the United Kingdom, where it is Class A. Ibogaine ceremony at Transcend in Vancouver operates legally. Medical screening is required regardless of legal status.

Who is not a candidate for ibogaine ceremony?

Absolute contraindications include: QT prolongation or significant cardiac arrhythmia, current SSRIs or SNRIs without a completed supervised taper (serotonin syndrome risk is real and potentially fatal), active psychosis or schizophrenia spectrum disorder, severe liver or kidney disease, pregnancy, lithium, most antipsychotics, and MAOIs. Someone in acute psychiatric crisis is also not an appropriate candidate regardless of motivation. The intake process exists to identify these conditions before ceremony, not to find ways around them.

How much does ibogaine ceremony cost in Vancouver?

At Transcend in Vancouver, ibogaine ceremony costs $2,000–$5,000 CAD. This includes the on-site physician present throughout the active experience, the medicine, and facilitation. Integration coaching is available separately at $150–$300 CAD per session. Providers charging significantly below this range are almost always removing safety infrastructure — the cost of an on-site physician and continuous cardiac monitoring is real.

What does the research show about ibogaine ceremony outcomes?

The 2023 Stanford study published in Nature Medicine found 88% reductions in PTSD symptoms, 87% in depression symptoms, and 81% in anxiety symptoms at one month post-treatment in 30 special operations veterans. Conventional antidepressant research considers a 50% reduction in depression scores a strong response. The study has a small sample and no placebo arm — genuine limitations that do not change the direction of the findings.

What an Ibogaine Ceremony Is — and Who Is Not a Candidate | Transcend

An ibogaine ceremony lasts 12–24 hours of active pharmacological experience. That window is not comfortable, not brief, and not appropriate for everyone. What follows — 2–3 days of supervised recovery and weeks of deliberate integration work — determines whether anything lasting changes.

An ibogaine ceremony involves a single oral dose of ibogaine — an alkaloid from the root bark of Tabernanthe iboga — administered under medical supervision. The active experience lasts 12–24 hours. A physician must be present throughout. An EKG is required before every ceremony. The 2023 Stanford study published in Nature Medicine found 88% reductions in PTSD symptoms, 87% in depression, and 81% in anxiety at one month post-treatment in 30 special operations veterans.

Dense forest canopy in low light — ibogaine ceremony takes place in a carefully controlled medical setting over 12–24 hours of active experience — Photo by Fabian Wiktor via Pexels

What an Ibogaine Ceremony Is

Ibogaine is an alkaloid extracted from the root bark of Tabernanthe iboga — a shrub native to Central Africa, used ceremonially by the Bwiti people of Gabon for centuries. The isolated compound is pharmacologically active in a way that whole-plant iboga is not in the same concentrations: ibogaine HCl and total alkaloid extract are the forms used in most clinical and non-Bwiti ceremonial contexts outside Central Africa.

A ceremony involves a single oral dose administered after medical screening confirms candidacy. The dose — typically 15–20 mg/kg of body weight — produces a visionary state that lasts 12–24 hours. Unlike psilocybin or MDMA, which produce their peak effects within a few hours, ibogaine is sustained. Most people spend 24–36 hours total in the facility before they are recovered enough to leave.

The experience is not recreational. Ibogaine shows people what they have been avoiding. The most consistent observation across practitioners is that the medicine does not deliver what people hope for — it delivers what they need, which is often not the same thing. The people who leave most disappointed are consistently the people who arrived with expectations the medicine does not serve.

For a detailed account of what ibogaine does at the neurological level — GDNF upregulation, the noribogaine metabolite, and the mechanism behind craving reduction — the guide to how ibogaine works covers this in detail.

What Happens During the 12–24 Hours

The first two to four hours are the most acute. The person lies down throughout — standing or walking is not possible during this phase due to ataxia, a cerebellar effect of ibogaine that temporarily impairs coordination. Visionary content typically begins within 30–60 minutes and may include intense autobiographical review, confrontation with suppressed material, and an encounter with patterns the person has been carrying for years.

Heart rate, blood pressure, and cardiac rhythm are monitored continuously throughout. An on-site physician is present. This is not a standard every provider meets. Some reduce costs by providing remote medical oversight or none at all.

Any provider offering ibogaine ceremony without a physician physically present during the active experience is not operating safely. Ibogaine prolongs the QT interval. The physician's role is not administrative — it is the difference between a complication that is managed and one that is not.

The peak typically resolves within 4–8 hours. The remaining time is quieter — still pharmacologically active, less visually intense, more reflective. Sleep is not typically possible during the active phase. By the end of the ceremony, most people have been awake for 18–30 hours.

The active metabolite of ibogaine — noribogaine — remains pharmacologically present for weeks to months after ceremony. This sustained presence underlies the extended period of elevated neuroplasticity that follows: a window during which new patterns are more accessible and during which integration work is most effective.

Person resting quietly in a dim room — the 12–24 hour active phase of ibogaine ceremony requires lying down throughout due to temporary ataxia — Photo via Pexels

What Medical Screening Involves

Medical screening is required before every ibogaine ceremony. It is not optional, and it is not a formality. It exists because ibogaine has real cardiac risks — and those risks are identifiable in advance with the right tests.

At Transcend in Vancouver, screening includes: a full medical history review, an EKG and cardiovascular assessment, a blood panel covering liver function, kidney function, and CBC, a review of all current medications and supplements, and a psychiatric history assessment.

The EKG is the most consequential test. Ibogaine blocks hERG potassium channels in cardiac tissue, prolonging the QT interval. In a person with pre-existing QT prolongation or arrhythmia, this can drive ventricular arrhythmia — the mechanism behind documented ibogaine-related deaths. The EKG identifies this risk in advance, before ceremony, when something can be done about it. A QTc above 450ms warrants evaluation; above 500ms is a hard stop.

The blood panel assesses liver and kidney function because ibogaine is metabolised hepatically via CYP2D6. Significant impairment slows clearance, extends the active experience unpredictably, and amplifies cardiac risk. Years of heavy alcohol use do not automatically mean liver damage — but the panel is required regardless of assumption.

Medication review is equally important. SSRIs, SNRIs, lithium, methadone, MAOIs, and several other drug classes interact with ibogaine in ways that are dangerous. Most of these are conditional contraindications — they require supervised preparation, not permanent disqualification. A few are absolute stops.

For the full breakdown of contraindications and what each one means for candidacy, the ibogaine contraindications guide covers every absolute and conditional disqualifier in detail.

Who Should Not Attend an Ibogaine Ceremony

Most ibogaine content online describes who this is for. This section is about who it is not for — and that question matters more.

Absolute contraindications — no protocol changes this:

QT prolongation, significant cardiac arrhythmia, or recent myocardial infarction
Current SSRIs or SNRIs without a completed supervised taper — a few days off the medication is not sufficient; washout must be medically managed
Active psychosis or schizophrenia spectrum disorder
Severe liver or kidney disease
Pregnancy
Lithium and most antipsychotic medications
MAOIs

Conditional contraindications — supervised preparation can address these:

SSRIs and SNRIs (supervised taper with prescribing physician required; washout period varies by medication — fluoxetine requires longer than sertraline or escitalopram)
Methadone (specific supervised transition protocol required; timeline measured in weeks to months, not days)
Some cardiac findings that require specialist evaluation before a decision is possible

Beyond the clinical contraindications: someone in acute psychiatric crisis is not an appropriate candidate regardless of motivation. The medicine amplifies what is present. Entering ibogaine ceremony in acute destabilisation does not produce stability — it produces a 12–24 hour encounter with what is most active, without the capacity to hold it. This is one of the most important conversations the intake process has, and also one of the hardest. Someone in crisis who has found a thread of hope does not receive a “no” easily. Saying it directly is an act of care, not rejection.

Person writing reflectively in a journal — integration work in the weeks following ibogaine ceremony determines whether the neuroplasticity window produces lasting change — Photo via Pexels

The Integration Period

The ceremony opens a window. The window does not stay open indefinitely. What is done in that window determines the outcome.

The people who arrive at ibogaine ceremony with the strongest results are often the ones who spent years trying everything else first — SSRIs that blunted rather than resolved, therapy that circled without landing, abstinence programmes that held for months and then did not. By the time they arrive, they are not naive about difficulty. They have evidence that other approaches were not enough. That scepticism, earned through sustained effort, tends to produce people who are genuinely prepared to encounter what the medicine shows them.

Contrast that with people who return immediately to the same environment, relationships, and unaddressed conditions that produced the original problem. The ceremony was equally profound. The clarity was real. But without deliberate integration work during the neuroplasticity window — typically 8–12 weeks post-ceremony — even a profound ceremony fades into an unusually vivid memory.

Integration coaching at Transcend — $150–$300 CAD per session — is not processing the ceremony for its own sake. It is translating what the ceremony showed into specific, concrete change: different relationships, different environments, different daily practice. That translation is the work. The ceremony makes it possible. Integration is where it happens.

For a detailed account of what the integration period involves and what happens neurologically during the noribogaine window, the integration page covers this in full.

What the Research Shows

The 2023 Stanford study, published in Nature Medicine, treated 30 special operations veterans with treatment-resistant PTSD, traumatic brain injury, and depression. At one month post-treatment: 88% average reduction in PTSD symptoms, 87% in depression symptoms, 81% in anxiety symptoms.

Conventional antidepressant research considers a 50% reduction in depression scores a strong response. The Stanford numbers — in a population that had already exhausted conventional treatment — are not marginal findings. They are consistent with what practitioners have observed for years.

The study is also limited. 30 veterans is not a definitive population. There is no placebo arm. The sample is specific. These are genuine methodological limitations that do not change the direction of the findings — but citing numbers without caveats is not honest, and the numbers are compelling enough to stand on their own with the caveats included.

The Texas clinical ibogaine programme — funded at $50 million USD across UTMB, UTHealth Houston, Texas A&M University, and Baylor University — represents the push to test these findings under controlled trial conditions. That funding is a signal about where the research is heading.

The Stanford study is available directly at Nature Medicine (2023). MAPS maintains a comprehensive ibogaine research overview covering decades of published work on ibogaine's clinical applications.

Cost of Ibogaine Ceremony in Vancouver

At Transcend in Vancouver, ibogaine ceremony costs $2,000–$5,000 CAD. That range includes the on-site medical professional present throughout the 12–24 hour ceremony, the medicine, and facilitation. It does not include integration coaching, which is available separately at $150–$300 CAD per session.

Providers charging significantly below this range are almost always reducing safety infrastructure. The cost of an on-site physician for 12–24 hours, continuous cardiac monitoring equipment, proper pre-ceremony screening, and the medicine itself is real. A $500 ibogaine ceremony is not a bargain. Something necessary is missing from that package, and what is missing usually determines whether the ceremony is safe.

For a breakdown of what drives cost variation between providers — and specifically which safety components cheaper providers typically eliminate — the ibogaine treatment center cost guide covers that in detail.

Frequently Asked Questions

What is the difference between an ibogaine ceremony and an iboga ceremony?: An iboga ceremony uses the whole root bark of Tabernanthe iboga in its traditional Bwiti form — typically involving music, chanting, and a ceremonial structure specific to the Gabonese and Cameroonian traditions in which iboga has been used for centuries. An ibogaine ceremony uses the isolated alkaloid — ibogaine HCl or total alkaloid extract — in a more clinical or hybrid facilitation context. The pharmacological core is similar; the ritual framework differs substantially. For the iboga ceremony specifically, the iboga ceremony guide covers the Bwiti tradition in detail.
How long does an ibogaine ceremony last?: The active pharmacological experience lasts 12–24 hours. Recovery — during which the person rests and is monitored — takes an additional 2–3 days. Most participants spend 4–5 days at the facility in total. The integration period that follows is the most consequential phase and typically runs 8–12 weeks.
Is ibogaine ceremony legal in Canada?: Ibogaine is not listed under Canada's Controlled Drugs and Substances Act and is not approved for medical use. It is not explicitly prohibited — a meaningfully different legal status from the United States, where ibogaine has been Schedule I since 1970, or the United Kingdom, where it is Class A. Ibogaine ceremony at Transcend in Vancouver operates legally. Medical screening is required regardless of legal status.
Can you do an ibogaine ceremony if you are on SSRIs?: Not without a completed supervised taper first. SSRIs are a conditional contraindication, not an absolute one. A supervised reduction under physician oversight — with a washout period that varies by medication — removes the serotonin syndrome risk. Fluoxetine requires a longer washout than sertraline or escitalopram. The taper must be medically supervised, not self-managed. Once it is complete, ceremony can proceed.
What does medical screening for ibogaine ceremony include?: An EKG and cardiovascular assessment, a blood panel covering liver function, kidney function, and CBC, a full medical history review, a review of all current medications and supplements, and a psychiatric history assessment. The EKG is the most critical element — it identifies pre-existing QT prolongation, which ibogaine can drive into arrhythmia. Any provider who does not require a pre-ceremony EKG is not operating safely.
How much does ibogaine ceremony cost in Vancouver?: At Transcend in Vancouver, ibogaine ceremony costs $2,000–$5,000 CAD. This includes the on-site physician, the medicine, and facilitation throughout. Integration coaching is available separately at $150–$300 CAD per session. Providers charging significantly less are almost always removing safety infrastructure — the cost of proper screening and an on-site physician is real, and cutting it has consequences.
Who is not a candidate for ibogaine ceremony?: Absolute contraindications include: QT prolongation or significant cardiac arrhythmia, current SSRIs or SNRIs without a completed supervised taper, active psychosis or schizophrenia spectrum disorder, severe liver or kidney disease, pregnancy, lithium, most antipsychotics, and MAOIs. Someone in acute psychiatric crisis is also not an appropriate candidate regardless of motivation. The intake process exists to identify these conditions before ceremony — not to find ways around them.
What does the research say about ibogaine ceremony outcomes?: The 2023 Stanford study published in Nature Medicine found 88% reductions in PTSD symptoms, 87% in depression symptoms, and 81% in anxiety symptoms at one month post-treatment in 30 special operations veterans. Conventional antidepressant research considers a 50% reduction in depression scores a strong response. The study has a small sample and no placebo arm — genuine limitations that do not change the direction of the findings.